These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6818831)

  • 21. Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay.
    Klinge J; Auerswald G; Budde U; Klose H; Kreuz W; Lenk H; Scandella D;
    Haemophilia; 2001 Jan; 7(1):26-32. PubMed ID: 11136377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apheresis.
    Nilsson IM; Freiburghaus C
    Adv Exp Med Biol; 1995; 386():175-84. PubMed ID: 8851026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development and characterisation of antibodies to human factor VIII in haemophilic dogs.
    Littlewood JD; Barrowcliffe TW
    Thromb Haemost; 1987 Jun; 57(3):314-21. PubMed ID: 3116702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of coagulation factor VIII inhibitors].
    Lutze G; Schlote A; Mittler U
    Z Gesamte Inn Med; 1980 Apr; 35(8):330-6. PubMed ID: 6776700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic studies of factor VIII coagulant activity (VIII:C) 1. Assays based on a haemophilic and an acquired antibody to VIII:C.
    Rotblat F; Tuddenham EG
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):431-45. PubMed ID: 6791294
    [No Abstract]   [Full Text] [Related]  

  • 26. Solid-phase immunoradiometric assay of factor-VIII protein.
    Counts RB
    Br J Haematol; 1975 Dec; 31(4):429-36. PubMed ID: 1088604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of a monoclonal antibody to factor VIII related antigen (VIIIRAg) in immunoradiometric assays for factor VIII.
    Thomas JE; Peake IR; Giddings JC; Welch AN; Bloom AL
    Thromb Haemost; 1985 Feb; 53(1):143-7. PubMed ID: 3922077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII antibody in a patient with mild haemophilia.
    Bovill EG; Burns SL; Golden EA
    Br J Haematol; 1985 Oct; 61(2):323-8. PubMed ID: 3929830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
    Parry DH; Bloom AL
    J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An ELISA assay for the detection of factor VIII antibodies - comparison with the conventional Bethesda assay in a large cohort of haemophilia samples.
    Shetty S; Ghosh K; Mohanty D
    Acta Haematol; 2003; 109(1):18-22. PubMed ID: 12486318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of blocking antibody in non-inhibitor haemophilic plasma.
    Pool J; Kaelin AC
    Thromb Haemost; 1977 Oct; 38(3):717-20. PubMed ID: 304261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A radial immunodiffusion method for the assay of factor VIII:C Antigen (VIII:C Ag) in plasma.
    McLellan DS; Devlin JD; Groom P; Aronstam A
    Br J Haematol; 1981 Feb; 47(2):295-305. PubMed ID: 6781528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose.
    Van Leeuwen EF; Mauser-Bunschoten EP; Van Dijken PJ; Kok AJ; Sjamsoedin-Visser EJ; Sixma JJ
    Br J Haematol; 1986 Oct; 64(2):291-7. PubMed ID: 3096366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG).
    Muller HP; van Tilburg NH; Bertina RM; Terwiel JP; Veltkamp JJ
    Clin Chim Acta; 1980 Oct; 107(1-2):11-9. PubMed ID: 6775848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.
    Rampersad AG; Boylan B; Miller CH; Shapiro A
    Haemophilia; 2018 Sep; 24(5):807-814. PubMed ID: 30004159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of haemophiliacs who have antibodies to factor VIII.
    Rizza CR
    Scand J Haematol Suppl; 1984; 40():187-93. PubMed ID: 6433451
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.